299 related articles for article (PubMed ID: 18630478)
1. Clinical efficacy of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis of localized prostate cancer.
Saito K; Kaminaga T; Muto S; Ide H; Nishio K; Kamiyama Y; Okada H; Terado Y; Furui S; Horie S
Anticancer Res; 2008; 28(3B):1899-904. PubMed ID: 18630478
[TBL] [Abstract][Full Text] [Related]
2. Proton MR spectroscopy of the prostate.
Mueller-Lisse UG; Scherr MK
Eur J Radiol; 2007 Sep; 63(3):351-60. PubMed ID: 17709223
[TBL] [Abstract][Full Text] [Related]
3. Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours.
Cirillo S; Petracchini M; Della Monica P; Gallo T; Tartaglia V; Vestita E; Ferrando U; Regge D
Clin Radiol; 2008 Aug; 63(8):871-9. PubMed ID: 18625351
[TBL] [Abstract][Full Text] [Related]
4. [1H magnetic resonance spectroscopy of the prostate].
Mueller-Lisse UG; Scherr M
Radiologe; 2003 Jun; 43(6):481-8. PubMed ID: 12827263
[TBL] [Abstract][Full Text] [Related]
5. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
6. The combination of multi-voxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer.
Hasumi M; Suzuki K; Taketomi A; Matsui H; Yamamoto T; Ito K; Kurokawa K; Aoki J; Endo K; Yamanaka H
Anticancer Res; 2003; 23(5b):4223-7. PubMed ID: 14666629
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
[TBL] [Abstract][Full Text] [Related]
8. Two-dimensional spectroscopic imaging for pretreatment evaluation of prostate cancer: comparison with the step-section histology after radical prostatectomy.
Weis J; Ahlström H; Hlavcak P; Häggman M; Ortiz-Nieto F; Bergman A
Magn Reson Imaging; 2009 Jan; 27(1):87-93. PubMed ID: 18599244
[TBL] [Abstract][Full Text] [Related]
9. [Value of 3D 1H-MRS with body coil at 3T in the differential diagnosis of the prostate cancer].
Wang F; Dai YP; Sun XZ; Guo Y; Chen YQ; Mao LJ; Wang DH; Deng CH
Zhonghua Nan Ke Xue; 2009 May; 15(5):431-6. PubMed ID: 19514556
[TBL] [Abstract][Full Text] [Related]
10. MR spectroscopy of prostate cancer. Initial clinical experience.
Squillaci E; Manenti G; Mancino S; Carlani M; Di Roma M; Colangelo V; Simonetti G
J Exp Clin Cancer Res; 2005 Dec; 24(4):523-30. PubMed ID: 16471314
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
12. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
Sciarra A; Panebianco V; Salciccia S; Osimani M; Lisi D; Ciccariello M; Passariello R; Di Silverio F; Gentile V
Eur Urol; 2008 Sep; 54(3):589-600. PubMed ID: 18226441
[TBL] [Abstract][Full Text] [Related]
13. Phased array magnetic resonance imaging for staging clinically localised prostrate cancer.
Borre M; Lundorf E; Marcussen N; Langkilde NC; Wolf H
Acta Oncol; 2005; 44(6):589-92. PubMed ID: 16294442
[TBL] [Abstract][Full Text] [Related]
14. MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer.
Hasumi M; Suzuki K; Oya N; Ito K; Kurokawa K; Fukabori Y; Yamanaka H
Anticancer Res; 2002; 22(2B):1205-8. PubMed ID: 12168926
[TBL] [Abstract][Full Text] [Related]
15. A qualitative approach to combined magnetic resonance imaging and spectroscopy in the diagnosis of prostate cancer.
Villeirs GM; Oosterlinck W; Vanherreweghe E; De Meerleer GO
Eur J Radiol; 2010 Feb; 73(2):352-6. PubMed ID: 19084363
[TBL] [Abstract][Full Text] [Related]
16. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer.
van Dorsten FA; van der Graaf M; Engelbrecht MR; van Leenders GJ; Verhofstad A; Rijpkema M; de la Rosette JJ; Barentsz JO; Heerschap A
J Magn Reson Imaging; 2004 Aug; 20(2):279-87. PubMed ID: 15269954
[TBL] [Abstract][Full Text] [Related]
17. MRI spectroscopy in screening of prostate cancer.
Goeb K; Engehausen DG; Krause FS; Hollenbach HP; Niedobitek G; Buettner M; Frangou P; Engelhard K
Anticancer Res; 2007; 27(1B):687-93. PubMed ID: 17348461
[TBL] [Abstract][Full Text] [Related]
18. Experience improves staging accuracy of endorectal magnetic resonance imaging in prostate cancer: what is the learning curve?
Latchamsetty KC; Borden LS; Porter CR; Lacrampe M; Vaughan M; Lin E; Conti N; Wright JL; Corman JM
Can J Urol; 2007 Feb; 14(1):3429-34. PubMed ID: 17324322
[TBL] [Abstract][Full Text] [Related]
19. Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate.
Fütterer JJ; Scheenen TW; Heijmink SW; Huisman HJ; Hulsbergen-Van de Kaa CA; Witjes JA; Heerschap A; Barentsz JO
Invest Radiol; 2007 Feb; 42(2):116-22. PubMed ID: 17220729
[TBL] [Abstract][Full Text] [Related]
20. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation.
Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX
Eur J Radiol; 2010 Feb; 73(2):345-51. PubMed ID: 19070978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]